Anna Knauer Elley
DKK 31 million grant from the Novo Nordisk Foundation will scale up current WDF partnerships in Tanzania
BAGSVÆRD, DENMARK - The World Diabetes Foundation (WDF) has received a DKK 31 million (USD 5 million) grant from the Novo Nordisk Foundation in support of a project in Tanzania aimed at strengthening access to care for people with diabetes and other non-communicable diseases (NCDs) as close to their homes and communities as possible.
The project will provide capacity-building at primary care and community levels across Tanzania by training thousands of healthcare workers, who will be given improved skills and resources to screen, diagnose and treat NCDs and also become better able to raise awareness in communities about NCDs and their underlying risk factors.
“This project aims to support Tanzania’s ambitious approach towards prevention and control of NCDs, whereby the health system would gradually move towards a more broadly defined system of healthcare that integrates NCDs such as diabetes and hypertension and other main disease groups and conditions,” says Leif Fenger Jensen, Managing Director, World Diabetes Foundation.
Further, to enhance the health literacy of children and adolescents and strengthen primary prevention in Tanzania, the project will support the national school health programme by training teachers at primary and secondary schools in all parts of the country.
Hanna Line Jakobsen, Head of Social, Humanitarian and Development Aid, Novo Nordisk Foundation, says: “Untreated diabetes or hypertension can lead to serious complications and loss of ability to work, which can be a disaster to the affected individuals, caregivers, families, households and their livelihoods. We hope that this project will not only make a big difference in Tanzania but also inspire the implementation of similar projects in other countries.”
Strong collaboration, replicable model
The grant is part of WDF’s strategy to increase support for national programmes to address diabetes and other NCDs in countries where partnerships have been ongoing for several years, and where a strong collaboration with the government and leading national stakeholders is in place. WDF has supported projects in Tanzania since 2003, over the past seven years in direct partnership with the Ministry of Health, Community Development, Gender, Elderly and Children, and more recently also with the President’s Office for Regional Administration and Local Government.
This new phase of collaboration, with the additional funding from Novo Nordisk Foundation, will enable the Tanzanian health authorities and health system to roll out several elements of its current NCD strategy and action plan.
This is the first time that WDF has applied to the Novo Nordisk Foundation, and the first time that WDF has received large scale funding for its partnership projects beyond its usual endowment.
The model of larger-scale support for national responses to diabetes and other NCDs may be replicated in more countries where WDF has reached advanced stages of collaboration.
The World Diabetes Foundation is an independent trust dedicated to the prevention and treatment of diabetes in the developing world.
Its aim is to alleviate human suffering related to diabetes and its complications among those least able to withstand the burden of the disease. The Foundation supports sustainable partnerships and acts as a catalyst to help others do more.
Since 2002, the WDF has provided USD 148.6 million in funding to 555 projects in 116 countries. For every dollar provided by WDF, about 2 dollars in cash or in-kind donations are contributed to the supported projects from other sources.
For more information, please visit
Anna Knauer Elley
World Diabetes Foundation
Phone: + 45 30 75 12 10